BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)

[Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results Full Year 2014 Financial Highlights · Net sales increased by $8.7 million, or 16.5%, year over year, from $52.7 million in 2013 to $61.4 million in 2014. · Gross profit grew by approximately 17.9% from $25.7 million in 2013 to $30.3 million in 2014. · Cash and] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): April 15, 2015 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T18:02:25+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

ALN [American Lorain] 10-K: (Original Filing)

[FORM 10-K December 31, 2014 For the fiscal year ended: For the transition period from ____________to ____________ 001-34449 AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer Identification Number) incorporation or organization) BeihuanZhong Road Junan County Shandong, People’s Republic of China, 276600 (86) 539-7317959 Title of each class Name of each exchange on which registered Common Stock,] [AMERICAN LORAIN CORPORATION SCHEDULE OF SUBSIDIARIES As of March 31, 2015 Subsidiaries of American Lorain Corporation Name Place of Incorporation International Lorain Holdings, Inc. Cayman Islands Junan Hongrun People’s Republic of China Shandong Lorain People’s Republic of China Dongguan Lorain People’s Republic of China Shandong Greenpia People’s Republic of China Beijing Lorain People’s Republic of China Luotian Lorain People’s Republic] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-160822) and Form S-3 (No. 333-164605 and No. 333-169815) of American Lorain Corporation of our report dated April 15, 2015 with respect to the consolidated financial statements of American Lorain Corporation, which report appears in this Annual Report] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Annual Report on Form 10-K of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Xiang Zhou, certify that: 1. I have reviewed this Annual Report on Form 10-K of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.]

By | 2016-04-03T02:57:42+00:00 April 15th, 2015|Categories: ALN, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

CCCR [China Commercial Credit] 10-K: (Original Filing)

[Form 10-K ☒ For the fiscal year ended December 31, 2014 ☐ For the transition period from China Commercial Credit, Inc. Delaware 45-4077653 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 1688, Yunli Road, Tongli Wujiang, Jiangsu Province People’s Republic of China 215200 (Zip Code) Issuer’s telephone number: (86-0512) 6396-0022 Title of each class Name] [I, Jingen Ling, certify that: 1. I have reviewed this annual report on Form 10-K for the period ended December 31, 2014 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Long Yi, certify that: 1 I have reviewed this annual report on Form 10-K for the period ended December 31, 2014 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingen Ling Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By | 2016-03-16T17:43:06+00:00 April 15th, 2015|Categories: CCCR, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 8-K: Biostar Pharmaceuticals, Inc. Announces Its Full Year and

[Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results Full Year 2014 Financial Highlights · Net sales increased by $8.7 million, or 16.5%, year over year, from $52.7 million in 2013 to $61.4 million in 2014. · Gross profit grew by approximately 17.9% from $25.7 million in 2013 to $30.3 million in 2014. · Cash and] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): April 15, 2015 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]

By | 2016-03-28T18:03:29+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

ALN [American Lorain] 10-K: FORM 10-K December 31, 2014 For the fiscal

[FORM 10-K December 31, 2014 For the fiscal year ended: For the transition period from ____________to ____________ 001-34449 AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer Identification Number) incorporation or organization) BeihuanZhong Road Junan County Shandong, People’s Republic of China, 276600 (86) 539-7317959 Title of each class Name of each exchange on which registered Common Stock,] [AMERICAN LORAIN CORPORATION SCHEDULE OF SUBSIDIARIES As of March 31, 2015 Subsidiaries of American Lorain Corporation Name Place of Incorporation International Lorain Holdings, Inc. Cayman Islands Junan Hongrun People’s Republic of China Shandong Lorain People’s Republic of China Dongguan Lorain People’s Republic of China Shandong Greenpia People’s Republic of China Beijing Lorain People’s Republic of China Luotian Lorain People’s Republic] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-160822) and Form S-3 (No. 333-164605 and No. 333-169815) of American Lorain Corporation of our report dated April 15, 2015 with respect to the consolidated financial statements of American Lorain Corporation, which report appears in this Annual Report] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Annual Report on Form 10-K of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Xiang Zhou, certify that: 1. I have reviewed this Annual Report on Form 10-K of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.]

By | 2016-04-03T02:59:03+00:00 April 15th, 2015|Categories: ALN, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

CCCR [China Commercial Credit] 10-K: Form 10-K ☒ For the fiscal year ended

[Form 10-K ☒ For the fiscal year ended December 31, 2014 ☐ For the transition period from China Commercial Credit, Inc. Delaware 45-4077653 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 1688, Yunli Road, Tongli Wujiang, Jiangsu Province People’s Republic of China 215200 (Zip Code) Issuer’s telephone number: (86-0512) 6396-0022 Title of each class Name] [I, Jingen Ling, certify that: 1. I have reviewed this annual report on Form 10-K for the period ended December 31, 2014 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [I, Long Yi, certify that: 1 I have reviewed this annual report on Form 10-K for the period ended December 31, 2014 of China Commercial Credit, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jingen Ling Chief Executive Officer] [SECTION 906 OF SARBANES-OXLEY ACT OF 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Long Yi Chief Financial Officer (Principal Financial and Accounting Officer)]

By | 2016-03-16T17:43:57+00:00 April 15th, 2015|Categories: CCCR, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 10-K: (Original Filing)

[FORM 10-K (Mark One) x December 31, 2014 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2014 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.3 5 ex23-3.htm EX-23.3] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.4 6 ex23-4.htm EX-23.4] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Ronghua Wang Chief Executive Officer EX-32.1 9 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Qinghua Liu Interim Chief Financial Officer EX-32.2 10 ex32-2.htm EX-32.2]

By | 2016-03-28T18:06:05+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

GOMO [Sungy Mobile] SC 13D: (Original Filing)

[AGREEMENT OF JOINT FILING Dated: April 15, 2015 Yuqiang Deng Yuqiang Deng Zhi Zhu Zhi Zhu Freedom First Holdings Limited Yuqiang Deng Director Credit Suisse Trust Limited Camille Le Conte Geoffrey Le Poidevin Authorised Signatory DENG Holdings Limited] [Proposal Letter April 13, 2015 The Board of Directors SUNGY MOBILE LIMITED (the “Company”) Floor 17, Tower A, China International Center No. 33 Zhongshan 3rd Road Yuexiu District, Guangzhou 510055 People’s Republic of China Dear Sirs and Madams: We, Yuqiang Deng and Zhi Zhu (collectively, “we” or “us”) are pleased to submit this preliminary non-binding proposal to acquire all of] [CUSIP No. 86737M 100 1. Name of Reporting Person. Yuqiang Deng 2. Check the Appropriate Box if a Member of a Group (See Instructions) x ¨ (a) 3. SEC Use Only 4. Source of Funds (See Instructions) OO – See Item 3 5. ¨ 6. Citizenship or Place of Organization People’s Republic of China]

By | 2016-03-18T18:27:46+00:00 April 15th, 2015|Categories: Chinese Stocks, GOMO, SEC Original|Tags: , , , , , |0 Comments
Read More

BSPM [Biostar Pharmaceuticals] 10-K: FORM 10-K (Mark One) x December 31, 2014

[FORM 10-K (Mark One) x December 31, 2014 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [Biostar Pharmaceuticals, Inc. List of subsidiaries As of December 31, 2014 Name Place of incorporation Shaanxi Biostar Biotech Ltd People’s Republic of China Shaanxi Aoxing Pharmaceutical Co. Ltd. People’s Republic of China Shaanxi Weinan Haren Pharmaceuticals, Ltd. People’s Republic of China EX-21 2 ex21.htm EX-21] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.1 3 ex23-1.htm EX-23.1] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Clement C. W. Chan & Co. Certified Public Accountants Hong Kong April 15, 2015 EX-23.2 4 ex23-2.htm EX-23.2] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.3 5 ex23-3.htm EX-23.3] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Mazars CPA Limited Certified Public Accountants Hong Kong April 15, 2015 EX-23.4 6 ex23-4.htm EX-23.4] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Ronghua Wang Chief Executive Officer EX-32.1 9 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: April 15, 2015 Qinghua Liu Interim Chief Financial Officer EX-32.2 10 ex32-2.htm EX-32.2]

By | 2016-03-28T18:07:39+00:00 April 15th, 2015|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More

GOMO [Sungy Mobile] SC 13D: AGREEMENT OF JOINT FILING Dated: April 15, 2015

[AGREEMENT OF JOINT FILING Dated: April 15, 2015 Yuqiang Deng Yuqiang Deng Zhi Zhu Zhi Zhu Freedom First Holdings Limited Yuqiang Deng Director Credit Suisse Trust Limited Camille Le Conte Geoffrey Le Poidevin Authorised Signatory DENG Holdings Limited] [Proposal Letter April 13, 2015 The Board of Directors SUNGY MOBILE LIMITED (the “Company”) Floor 17, Tower A, China International Center No. 33 Zhongshan 3rd Road Yuexiu District, Guangzhou 510055 People’s Republic of China Dear Sirs and Madams: We, Yuqiang Deng and Zhi Zhu (collectively, “we” or “us”) are pleased to submit this preliminary non-binding proposal to acquire all of] [CUSIP No. 86737M 100 1. Name of Reporting Person. Yuqiang Deng 2. Check the Appropriate Box if a Member of a Group (See Instructions) x ¨ (a) 3. SEC Use Only 4. Source of Funds (See Instructions) OO – See Item 3 5. ¨ 6. Citizenship or Place of Organization People’s Republic of China]

By | 2016-03-18T18:28:44+00:00 April 15th, 2015|Categories: Chinese Stocks, GOMO, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar